Glycemic and lipid responses to glucomannan in Thais with type 2 diabetes mellitus

Journal of the Medical Association of Thailand

Volumn 90, Issue 10, 2007, Pages 2150-2157

  Chearskul, Supornpim ^a   Sangurai, Somkiat ^a   Nitiyanant, Wannee ^a   Kriengsinyos, Wantanee ^b   Kooptiwut, Suwattanee ^a   Harindhanavudhi, Tasma ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Glucomannan; OGTT; Soluble dietary fiber; Thais; Type 2 diabetes

Indexed keywords

FRUCTOSAMINE; GLUCOSE; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MANNAN; ORAL ANTIDIABETIC AGENT; PLACEBO;

ADULT; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CHRONOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; DIET THERAPY; FEMALE; GLUCOSE ABSORPTION; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; LIPID BLOOD LEVEL; LOOSE FECES; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; STATISTICAL SIGNIFICANCE; THAILAND; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; AGED; AREA UNDER CURVE; BLOOD GLUCOSE; BODY MASS INDEX; CATHARTICS; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE TOLERANCE TEST; GLYCEMIC INDEX; HEALTH STATUS INDICATORS; HUMANS; INSULIN; INSULIN RESISTANCE; LIPIDS; MALE; MANNANS; MIDDLE AGED; THAILAND;

EID: 35848967364     PISSN: 01252208     EISSN: 01252208     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998; 21: 1414-31.
2. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321: 405-12.
3. Gerich JE. The importance of tight glycemic control. Am J Med 2005; 118(Suppl 9A): 7S-11S.
4. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2004; 27(Suppl 1): S15-35.
5. Laakso M. Lipids in type 2 diabetes. Semin Vasc Med 2002; 2: 59-66.
6. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004; 110: 227-39.
7. Franz MJ, Bantle JP, Beebe CA, Brunzell JD, Chiasson JL, Garg A, et al. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care 2003; 26(Suppl 1): S51-S61.
8. Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, Sherwin R, et al. Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2006; 29: 1963-72.
9. Riccardi G, Rivellese AA. Effects of dietary fiber and carbohydrate on glucose and lipoprotein metabolism in diabetic patients. Diabetes Care 1991; 14: 1115-25.
10. Del Toma E, Lintas C, Clementi A, Marcelli M. Soluble and insoluble dietary fibre in diabetic diets. Eur J Clin Nutr 1988; 42: 313-9.
11. Vuksan V, Jenkins DJ, Spadafora P, Sievenpiper JL, Owen R, Vidgen E, et al. Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. A randomized controlled metabolic trial. Diabetes Care 1999; 22: 913-9.
12. Chen HL, Sheu WH, Tai TS, Liaw YP, Chen YC. Konjac supplement alleviated hypercholesterolemia and hyperglycemia in type 2 diabetic subjects - a randomized double-blind trial. J Am Coll Nutr 2003; 22: 36-42.
13. Shima K, Tanaka A, Ikegami H, Tabata M, Sawazaki N, Kumahara Y. Effect of dietary fiber, glucomannan, on absorption of sulfonylurea in man. Horm Metab Res 1983; 15: 1-3.
14. Avignon A, Monnier L. Specific effect of postprandial glycemic peaks on HBA1c and angiopathy. Diabetes Metab 2000; 26(Suppl 2): 12-5.
15. DECODE Study Group. The European Diabetes Epidemiology Group. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 2001; 161: 397-405.
16. Armbruster DA. Fructosamine: structure, analysis, and clinical usefulness. Clin Chem 1987; 33: 2153-63.
17. nd ed. Nakhonpathom,Thailand: Institute of Nutrition, Mahidol University; 2002.
18. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-9.
19. Doi K, Matsuura M, Kawara A, Baba S. Treatment of diabetes with glucomannan (konjac mannan). Lancet 1979; 1: 987-8.
20. Magnati G, Arsenio L, Bodria P, Lateana M, Strata A. Dietary fiber and OGTT: blood sugar variations after administration of a new purified glucomannane. Acta Biomed Ateneo Parmense 1984; 55: 5-14.
21. Jenkins DJ, Wolever TM, Leeds AR, Gassull MA, Haisman P, Dilawari J, et al. Dietary fibres, fibre analogues, and glucose tolerance: importance of viscosity. Br Med J 1978; 1: 1392-4.
22. Huang CY, Zhang MY, Peng SS, Hong JR, Wang X, Jiang HJ, et al. Effect of Konjac food on blood glucose level in patients with diabetes. Biomed Environ Sci 1990; 3: 123-31.
23. Misciagna G, Logroscino G, De Michele G, Cisternino AM, Guerra V, Freudenheim JL. Fructosamine, glycated hemoglobin, and dietary carbohydrates. Clin Chim Acta 2004; 340: 139-47.
24. Basu R, Dalla MC, Campioni M, Basu A, Klee G, Toffolo G, et al. Effects of age and sex on postprandial glucose metabolism: differences in glucose turnover, insulin secretion, insulin action, and hepatic insulin extraction. Diabetes 2006; 55: 2001-14.
25. Turner RC, Millns H, Neil HA, Stratton IM, Manley SE, Matthews DR, et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). BMJ 1998; 316: 823-8.
26. Vuksan V, Sievenpiper JL, Xu Z, Wong EY, Jenkins AL, Beljan-Zdravkovic U, et al. Konjac-Mannan and American ginsing: emerging alternative therapies for type 2 diabetes mellitus. J Am Coll Nutr 2001; 20(5 Suppl): 370S-83S.
27. Aekplakorn W, Kosulwat V, Suriyawongpaisal P. Obesity indices and cardiovascular risk factors in Thai adults. Int J Obes (Lond) 2006; 30: 1782-90.
28. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-53.
29. Lean ME, Powrie JK, Anderson AS, Garthwaite PH. Obesity, weight loss and prognosis in type 2 diabetes. Diabet Med 1990; 7: 228-33.
30. Walsh DE, Yaghoubian V, Behforooz A. Effect of glucomannan on obese patients: a clinical study. Int J Obes 1984; 8: 289-93.